Hypoxia-induced expression of bradykinin type-2 receptors in endothelial cells triggers NO production, cell migration, and angiogenesis

Journal of Cellular Physiology

Volumn 221, Issue 2, 2009, Pages 359-366

  Liesmaa, Inka ^a   Leskinen, Hanna K ^b   Kokkonen, Jorma O ^c   Ruskoaho, Heikki ^b   Kovanen, Petri T ^a   Lindstedt, Ken A ^a  

^a WIHURI RESEARCH INSTITUTE   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR ANTAGONIST; ICATIBANT; MESSENGER RNA; NITRIC OXIDE; OXYGEN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DISEASE SEVERITY; DRUG INHIBITION; ENDOTHELIUM CELL; HEART INFARCTION; HEART MUSCLE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOXIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; SCAR; TISSUE LEVEL; VASCULAR ENDOTHELIUM; VASCULAR FIBROSIS; WESTERN BLOTTING; WOUND HEALING; ANIMAL; ANOXIA; BIOSYNTHESIS; CELL CULTURE; CELL MOTION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; WISTAR RAT;

RATTUS;

ANIMALS; ANOXIA; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE; RATS; RATS, WISTAR; RECEPTOR, BRADYKININ B2; RNA, MESSENGER;

EID: 70149094585     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21861     Document Type: Article

References (36)

1. Bledsoe G, Chao L, Chao J. 2003. Kallikrein gene delivery attenuates cardiac remodeling and promotes neovascularization in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 285:H1479-H1488. (Pubitemid 37169501)
2. Buzza MS, Zamurs L, Sun J, Bird CH, Smith AI, Trapani JA, Froelich CJ, Nice EC, Bird PI. 2005. Extracellular matrix remodeling by human Granzyme B via cleavage of vitronectin, fibronectin, and laminin. J Biol Chem 280:23549-23558. (Pubitemid 40884833)
3. Emanueli C, Minasi A, Zacheo A, Chao J, Chao L, Salis MB, Straino S, Tozzi MG, Smith R, Gaspa L, Bianchini G, Stillo F, Capogrossi MC, Madeddu P. 2001. Local delivery of human tissue kallikrein gene accelerates spontaneous angiogenesis in mouse model of hindlimb ischemia. Circulation 103:125-132. (Pubitemid 32050447)
4. Endemann DH, Schiffrin EL. 2004. Endothelial dysfunction. J Am Soc Nephrol 15:1983-1992.
5. Ferdinand KC. 2007. African American heart failure trial: Role of endothelial dysfunction and heart failure in African Americans. Am J Cardiol 99:3D-6D.
6. Gohlke P, Kuwer I, Schnell A, Amann K, Mall G, Unger T. 1997. Blockade of bradykinin B2 receptors prevents the increase in capillary density induced by chronic angiotensin-converting enzyme inhibitor treatment in stroke-prone spontaneously hypertensive rats. Hypertension 29:478-482. (Pubitemid 27074086)
7. Groves P, Kurz S, Just H, Drexler H. 1995. Role of endogenous bradykinin in human coronary vasomotor control. Circulation 92:3424-3430.
8. Hall JM. 1992. Bradykinin receptors: Pharmacological properties and biological roles. Pharmacol Ther 56:131-190. (Pubitemid 23085319)
9. Hecquet C, Tan F, Marcic BM, Erdos EG. 2000. Human bradykinin B(2) receptor is activated by kallikrein and other serine proteases. Mol Pharmacol 58:828-836. (Pubitemid 30761299)
10. Heikkila HM, Latti S, Leskinen MJ, Hakala JK, Kovanen PT, Lindstedt KA. 2008. Activated mast cells induce endothelial cell apoptosis by a combined action of chymase and tumor necrosis factor-{alpha}. Arterioscler Thromb Vasc Biol 28:309-314.
11. Houle S, Larrivee JF, Bachvarova M, Bouthillier J, Bachvarov DR, Marceau F. 2000. Antagonist-induced intracellular sequestration of rabbit bradykinin B(2) receptor. Hypertension 35:1319-1325. (Pubitemid 30413671)
12. Kitakaze M, Node K, Minamino T, Asanuma H, Ueda Y, Kosaka H, Kuzuya T, Hori M. 1998. Inhibition of angiotensin-converting enzyme increases the nitric oxide levels in canine ischemic myocardium. J Mol Cell Cardiol 30:2461-2466. (Pubitemid 28549995)
13. Kuoppala A, Shiota N, Kokkonen JO, Liesmaa I, Kostner K, Mayranpaa M, Kovanen PT, Lindstedt KA. 2002. Down-regulation of cardioprotective bradykinin type-2 receptors in the left ventricle of patients with end-stage heart failure. J Am Coll Cardiol 40:119-125. (Pubitemid 34701386)
14. Kuoppala A, Shiota N, Lindstedt KA, Rysa J, Leskinen HK, Luodonpaa M, Liesmaa I, Ruskoaho H, Kaaja R, Kovanen PT, Kokkonen JO. 2003. Expression of bradykinin receptors in the left ventricles of rats with pressure overload hypertrophy and heart failure. J Hypertens 21:1729-1736. (Pubitemid 37076357)
15. Liang CC, Park AY, Guan JL. 2007. In vitro scratch assay: A convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2:329-333.
16. Liesmaa I, Kokkonen JO, Kovanen PT, Lindstedt KA. 2007. Lovastatin induces the expression of bradykinin type 2 receptors in cultured human coronary artery endothelial cells. J Mol Cell Cardiol 43:593-600. (Pubitemid 47615049)
17. Liu YH, Yang XP, Sharov VG, Nass O, Sabbah HN, Peterson E, Carretero OA. 1997. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors. J Clin Invest 99:1926-1935. (Pubitemid 27175940)
18. Maestri R, Milia AF, Salis MB, Graiani G, Lagrasta C, Monica M, Corradi D, Emanueli C, Madeddu P. 2003. Cardiac hypertrophy and microvascular deficit in kinin B2 receptor knockout mice. Hypertension 41:1151-1155. (Pubitemid 36548618)
19. Manalo DJ, Rowan A, Lavoie T, Natarajan L, Kelly BD, Ye SQ, Garcia JGN, Semenza GL. 2005. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 105:659-669. (Pubitemid 40070750)
20. Marceau F, Larrivee JF, Bouthillier J, Bachvarova M, Houle S, Bachvarov DR. 1999. Effect of endogenous kinins, prostanoids, and NO on kinin B1 and B2 receptor expression in the rabbit. Am J Physiol 277:R1568-R1578. (Pubitemid 30043762)
21. McDonald KM, Mock J, D'Aloia A, Parrish T, Hauer K, Francis G, Stillman A, Cohn JN. 1995. Bradykinin antagonism inhibits the antigrowth effect of converting enzyme inhibition in the dog myocardium after discrete transmural myocardial necrosis. Circulation 91:2043-2048.
22. Miura Si, Matsuo Y, Saku K. 2003. Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells. Hypertension 41:1118-1123. (Pubitemid 36548613)
23. Munk VC, Sanchez de ML, Petrimpol M, Butz N, Banfi A, Eriksson U, Hein L, Humar R, Battegay EJ. 2007. Angiotensin II induces angiogenesis in the hypoxic adult mouse heart in vitro through an AT2-B2 receptor pathway. Hypertension 49:1178-1185. (Pubitemid 351664302)
24. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, Braunwald E. 1979. Myocardial infarct size and ventricular function in rats. Circ Res 44:503-512. (Pubitemid 9170880)
25. Regitz-Zagrosek V, Neuss M, Holzmeister J, Fleck E. 1995. Use of angiotensin II antagonists in human heart failure: Function of the subtype 1 receptor. J Hypertens Suppl 13:S63-S71.
26. Sanchez de ML, Neysari S, Jakob S, Petrimpol M, Butz N, Banfi A, Zaugg CE, Humar R, Battegay EJ. 2008. B2-kinin receptor plays a key role in B1-, angiotensin converting enzyme inhibitor, and vascular endothelial growth factor-stimulated in vitro angiogenesis in the hypoxic mouse heart. Cardiovasc Res 80:106-113.
27. Semenza GL. 2000. HIF-1 and human disease: One highly involved factor. Genes Dev 14:1983-1991.
28. Semenza GL. 2003. Angiogenesis in ischemic and neoplastic disorders. Annu Rev Med 54:17-28.
29. Silvestre JS, Bergaya S, Tamarat R, Duriez M, Boulanger CM, Levy BI. 2001. Proangiogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B2 receptor pathway. Circ Res 89:678-683. (Pubitemid 34627067)
30. Su JB, Barbe F, Houel R, Guyene TT, Crozatier B, Hittinger L. 1998. Preserved vasodilator effect of bradykinin in dogs with heart failure. Circulation 98:2911-2918. (Pubitemid 29003975)
31. Tenhunen O, Soini Y, Ilves M, Rysa J, Tuukkanen J, Serpi R, Pennanen H, Ruskoaho H, Leskinen H. 2006. p38 Kinase rescues failing myocardium after myocardial infarction: Evidence for angiogenic and anti-apoptotic mechanisms. FASEB J 20:1907-1909.
32. Thuringer D, Maulon L, Frelin C. 2002. Rapid transactivation of the vascular endothelial growth factor receptor KDR/Flk-1 by the bradykinin B2 receptor contributes to endothelial nitric-oxide synthase activation in cardiac capillary endothelial cells. J Biol Chem 277:2028-2032. (Pubitemid 34968784)
33. Toth M, Shenk T. 1994. Antagonist-mediated down-regulation of 5-hydroxytryptamine type 2 receptor gene expression: Modulation of transcription. Mol Pharmacol 45:1095-1100. (Pubitemid 24195565)
34. Uruno A, Sugawara A, Kanatsuka H, Kagechika H, Saito A, Sato K, Kudo M, Takeuchi K, Ito S. 2005. Upregulation of nitric oxide production in vascular endothelial cells by all-trans retinoic acid through the phosphoinositide 3-kinase/Akt pathway. Circulation 112:727-736. (Pubitemid 41099053)
35. Wollert KC, Studer R, Doerfer K, Schieffer E, Holubarsch C, Just H, Drexler H. 1997. Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat. Circulation 95:1910-1917. (Pubitemid 27164410)
36. Yang XP, Liu YH, Scicli GM, Webb CR, Carretero OA. 1997. Role of kinins in the cardioprotective effect of preconditioning: Study of myocardial ischemia/reperfusion injury in B2 kinin receptor knockout mice and kininogen-deficient rats. Hypertension 30:735-740.